IP Library › Granted Patent US 11,077,030
Granted Patent B2
US 11,077,030 · App. 16/581,998 · Granted Aug 3, 2021

Sunscreen formulation

Inventors: David J. Milora (Blue Bell, PA); Harry Fallick (Wayne, PA)
Assignee: FALLIEN COSMECEUTICALS, LTD.
A61K8/046A61K8/0241A61K8/19A61K8/27A61K8/29A61K8/37A61K8/375A61K8/4993A61K8/60A61K8/731A61K8/8147A61K8/8152A61K8/8176A61K8/85A61K8/86A61K8/87A61Q17/04A61K2800/21A61K2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,077,030
App. No.
16/581,998
Granted
Aug 3, 2021
Kind
B2
Abstract

The present application relates to sunscreen formulations, including foamable sunscreen formulations, that comprise zinc oxide and titanium dioxide particles, suitably in the size range of about 1-100 nm. The compositions suitably produce a minimal residual whitening effect when applied to a skin surface.

Claims (37)

1. A sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % active particles having a primary particle size of about 10 nm to about 500 nm;

b. about 0.1 wt % to about 20 wt % emulsion stabilizer;

c. about 0.01 wt % to about 30 wt % skin conditioner;

d. about 0.01 wt % to about 20 wt % emulsifier; and

e. about 0.05 wt % to about 20 wt % suspending agent,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

2. The sunscreen formulation of claim 1 , wherein the active particles have a primary particle size of about 10 nm to about 200 nm.

3. The sunscreen formulation of claim 1 , wherein the active particles comprise titanium dioxide particles, zinc oxide particles, or both.

4. The sunscreen formulation of claim 1 , wherein the active particles comprise about 1 wt % to about 10 wt % titanium dioxide particles.

5. The sunscreen formulation of claim 1 , wherein the active particles comprise about 1 wt % to about 20 wt % zinc oxide particles.

6. The sunscreen formulation of claim 1 , wherein the active particles comprise about 1 wt % to about 10 wt % titanium dioxide particles and about 1 wt % to about 10 wt % zinc oxide particles.

7. The sunscreen formulation of claim 1 , wherein the emulsion stabilizer is selected from microcrystalline cellulose, cellulose gum, xanthan gum, magnesium aluminum silicate, bentonite clay, hectorite clay, and combination thereof.

8. The sunscreen formulation of claim 1 , wherein the skin conditioner is selected from C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, fatty acid esters of C 8 or greater, mineral oil, and combination thereof.

9. The sunscreen formulation of claim 1 , wherein the emulsifier is selected from glyceryl stearate, ceteareth-20, polysorbate 80, sodium lauryl sulfate, lecithin, and combination thereof.

10. The sunscreen formulation of claim 1 , wherein the suspending agent is selected from polyhydroxystearic acid, sodium polyacrylate polymer, methyl methacrylate crosspolymer, and combination thereof.

11. The sunscreen formulation of claim 1 , further consisting essentially of about 0.01 wt % to about 1 wt % iron oxide particles.

12. The sunscreen formulation of claim 1 , further consisting essentially of a film former.

13. The sunscreen formulation of claim 12 , wherein the film former is selected from polyurethane-2, polymethyl methacrylate, tricontanyl poly(vinyl pyrollidone) (PVP), vinyl pyrollidone/eicosene copolymer, and combination thereof.

14. A sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % zinc oxide particles having a primary particle size of about 10 nm to about 500 nm; about 1 wt % to about 25 wt % titanium dioxide particles having a primary particle size of about 10 nm to about 500 nm; or a combination thereof;

b. an emulsion stabilizer;

c. a skin conditioner;

d. an emulsifier; and

e. a suspending agent,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

15. The sunscreen formulation of claim 14 , wherein the emulsion stabilizer is selected from microcrystalline cellulose, cellulose gum, xanthan gum, magnesium aluminum silicate, bentonite clay, hectorite clay, and combination thereof.

16. The sunscreen formulation of claim 14 , wherein the skin conditioner is selected from C 12-15 alkyl benzoate, octyldodecyl neopentanoate, butyl octyl salicylate, caprylyl glycol, glycerin, fatty acid esters of C 8 or greater, mineral oil, and combination thereof.

17. The sunscreen formulation of claim 14 , wherein the emulsifier is selected from glyceryl stearate, ceteareth-20, polysorbate 80, sodium lauryl sulfate, lecithin, and combination thereof.

18. The sunscreen formulation of claim 14 , wherein the suspending agent is selected from polyhydroxystearic acid, sodium polyacrylate polymer, methyl methacrylate crosspolymer, and combination thereof.

19. A sunscreen formulation consisting essentially of:

a. about 1 wt % to about 25 wt % zinc oxide particles having a primary particle size of about 10 nm to about 500 nm; about 1 wt % to about 25 wt % titanium dioxide particles having a primary particle size of about 10 nm to about 500 nm; or a combination thereof;

b. about 0.1 wt % to about 20 wt % emulsion stabilizer;

c. about 0.01 wt % to about 30 wt % skin conditioner; and

d. about 0.01 wt % to about 20 wt % emulsifier,

wherein the formulation produces a minimal residual whitening effect when applied to a skin surface.

20. The sunscreen formulation of claim 19 , further consisting essentially of a suspending agent, a film former, or both.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2019
From: MILORA, DAVID J.; FALLICK, HARRY
To: FALLIEN COSMECEUTICALS, LTD.
Reel/Frame 050485/0964 →
Continuity (6)
Continuation 15856190 · Dec 28, 2017
Continuation 15387709 · Dec 22, 2016
Continuation 14539217 · Nov 12, 2014
Continuation 13648707 · Oct 10, 2012
Provisional Application 61545848 · Oct 11, 2011
Related Publication 20200016047A1 · Jan 16, 2020
Cited By (1)
US 12,728,081